VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 64 filers reported holding VENTYX BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,666,067 | -27.6% | 47,972 | -31.7% | 0.00% | – |
| Q2 2023 | $2,302,134 | -11.5% | 70,187 | -9.6% | 0.00% | – |
| Q1 2023 | $2,602,215 | +47.7% | 77,678 | +44.6% | 0.00% | – |
| Q4 2022 | $1,761,807 | +369.8% | 53,730 | +399.1% | 0.00% | – |
| Q3 2022 | $375,000 | +92.3% | 10,765 | -32.6% | 0.00% | – |
| Q2 2022 | $195,000 | -53.1% | 15,963 | -48.0% | 0.00% | – |
| Q1 2022 | $416,000 | -55.4% | 30,680 | -34.6% | 0.00% | – |
| Q4 2021 | $932,000 | – | 46,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |